RITUXIMAB OBJECTIVE OUTCOME MEASURES TRIAL IN SLE (ROOTS): A DOUBLE-BLIND RANDOMISED PLACEBO-CONTROLLED FEASIBILITY TRIAL

被引：0
|
作者：
Mahmoud, K. [1 ,2 ]
Wilson, M. [1 ,2 ]
Yusof, M. Y. Md [1 ,2 ]
Brown, S. [3 ]
Hensor, E. [1 ,2 ]
Vital, E. [1 ,2 ]
机构：
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS trust, NIHR Biomed Res Ctr, Leeds, W Yorkshire, England
[3] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Randomized control trial; Systemic lupus erythematosus; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.7022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LB0005
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [21] Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum
    Whittaker, R
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2003, 110 (01) : 88 - 88
  • [22] Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial
    Donato, Francesco
    Raffetti, Elena
    Toninelli, Giuseppe
    Festa, Andrea
    Scarcella, Carmelo
    Castellano, Maurizio
    COMPLEMENTARY MEDICINE RESEARCH, 2021, 28 (03) : 216 - 225
  • [23] Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial
    Tahan, F.
    Ozcan, A.
    Koc, N.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (01) : 91 - 97
  • [24] Montelukast and bronchial inflammation in asthma: A randomised, double-blind placebo-controlled trial
    Ramsay, C. F.
    Sullivan, P.
    Gizycki, M.
    Wang, D.
    Swern, A. S.
    Barnes, N. C.
    Reiss, T. F.
    Jeffery, P. K.
    RESPIRATORY MEDICINE, 2009, 103 (07) : 995 - 1003
  • [25] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [26] Efficacy of rituximab in patients with polymyalgia rheumatica: a double-blind, randomised, placebo-controlled, proof-of-concept trial
    Marsman, Diane E.
    den Broeder, Nathan
    van den Hoogen, Frank H. J.
    den Broeder, Alfons A.
    van der Maas, Aatke
    LANCET RHEUMATOLOGY, 2021, 3 (11): : E758 - E766
  • [27] OUTCOME MEASURES IN RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND MULTIPLE-SCLEROSIS CLINICAL-TRIAL
    NOSEWORTHY, JH
    OBRIEN, PC
    NAESSENS, JM
    NEUROLOGY, 1994, 44 (04) : A392 - A392
  • [28] BROMOCRIPTINE IN MANIA - PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL
    SMITH, AHW
    CHAMBERS, C
    NAYLOR, GJ
    BRITISH MEDICAL JOURNAL, 1980, 280 (6207): : 86 - 86
  • [29] NIFEDIPINE FOR EPILEPSY - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    LARKIN, JG
    BESAG, FMC
    COX, A
    WILLIAMS, J
    BRODIE, MJ
    EPILEPSIA, 1992, 33 (02) : 346 - 352
  • [30] Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
    Ghanima, Waleed
    Khelif, Abderrahim
    Waage, Anders
    Michel, Marc
    Tjonnfjord, Geir E.
    Ben Romdhan, Neila
    Kahrs, Johannes
    Darne, Bernadette
    Holme, Pal Andre
    LANCET, 2015, 385 (9978): : 1653 - 1661
12345